2000
$170M
from 16 investors over 16 rounds
Xanodyne Pharmaceuticals, Inc. raised $88M on October 30, 2009
Investors: Aisling Capital, Union Spring Pharmaceuticals, Longitude Capital, Silver Point Capital, HealthCare Ventures LLC, MPM Capital and Blue Chip Venture Company
Xanodyne Pharmaceuticals, Inc. raised $25M on July 27, 2007
Investors: Aisling Capital, Blue Chip Venture Company, MPM Capital, Apax and HealthCare Ventures LLC
Xanodyne Pharmaceuticals, Inc. raised $170M on July 25, 2005
Investors: Apax, HealthCare Ventures LLC and MPM Capital
Xanodyne Pharmaceuticals, Inc. raised $20M on June 23, 2004
Investors: HealthCare Ventures LLC